K. Roger Aoki

7.2k total citations · 1 hit paper
102 papers, 5.5k citations indexed

About

K. Roger Aoki is a scholar working on Neurology, Cellular and Molecular Neuroscience and Molecular Biology. According to data from OpenAlex, K. Roger Aoki has authored 102 papers receiving a total of 5.5k indexed citations (citations by other indexed papers that have themselves been cited), including 65 papers in Neurology, 38 papers in Cellular and Molecular Neuroscience and 11 papers in Molecular Biology. Recurrent topics in K. Roger Aoki's work include Botulinum Toxin and Related Neurological Disorders (65 papers), Neurological disorders and treatments (44 papers) and Hereditary Neurological Disorders (31 papers). K. Roger Aoki is often cited by papers focused on Botulinum Toxin and Related Neurological Disorders (65 papers), Neurological disorders and treatments (44 papers) and Hereditary Neurological Disorders (31 papers). K. Roger Aoki collaborates with scholars based in United States, Ireland and Japan. K. Roger Aoki's co-authors include J. Oliver Dolly, John Rubino, Minglei Cui, Anton de Paiva, Frédéric A. Meunier, Jordi Molgó, Joseph Francis, M. Zouhair Atassi, Gary W. Lawrence and Lance E. Steward and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and PLoS ONE.

In The Last Decade

K. Roger Aoki

99 papers receiving 5.3k citations

Hit Papers

Recent development of flow visualization 2004 2026 2011 2018 2004 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
K. Roger Aoki United States 34 3.9k 1.4k 1.4k 1.0k 499 102 5.5k
Markus Naumann Germany 38 3.4k 0.9× 1.4k 1.0× 1.3k 1.0× 399 0.4× 367 0.7× 117 5.4k
Karlheinz Reiners Germany 47 3.8k 1.0× 1.9k 1.4× 1.1k 0.8× 594 0.6× 790 1.6× 153 6.9k
Lucio Santoro Italy 45 3.5k 0.9× 2.9k 2.1× 1.1k 0.8× 442 0.4× 288 0.6× 254 7.0k
Reiner Benecke Germany 38 2.7k 0.7× 1.3k 0.9× 555 0.4× 509 0.5× 344 0.7× 101 5.5k
Roberto Eleopra Italy 35 2.9k 0.7× 1.1k 0.8× 697 0.5× 260 0.3× 203 0.4× 133 4.0k
Volker Tronnier Germany 44 3.1k 0.8× 1.2k 0.9× 734 0.5× 420 0.4× 858 1.7× 194 6.1k
M. Naumann Germany 28 2.1k 0.5× 559 0.4× 907 0.7× 417 0.4× 246 0.5× 62 3.1k
M. Manfredi Italy 56 4.0k 1.0× 2.0k 1.4× 1.1k 0.8× 1.8k 1.7× 1.3k 2.6× 238 10.1k
Jasper R. Daube United States 48 3.6k 0.9× 1.9k 1.3× 710 0.5× 283 0.3× 602 1.2× 154 6.8k
Machiel J. Zwarts Netherlands 48 2.2k 0.6× 1.6k 1.1× 872 0.6× 984 1.0× 297 0.6× 166 8.1k

Countries citing papers authored by K. Roger Aoki

Since Specialization
Citations

This map shows the geographic impact of K. Roger Aoki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K. Roger Aoki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K. Roger Aoki more than expected).

Fields of papers citing papers by K. Roger Aoki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by K. Roger Aoki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K. Roger Aoki. The network helps show where K. Roger Aoki may publish in the future.

Co-authorship network of co-authors of K. Roger Aoki

This figure shows the co-authorship network connecting the top 25 collaborators of K. Roger Aoki. A scholar is included among the top collaborators of K. Roger Aoki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with K. Roger Aoki. K. Roger Aoki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Oshima, Minako, Philip R. Deitiker, Tandy Hastings‐Ison, et al.. (2017). Antibody responses to botulinum neurotoxin type A of toxin-treated spastic equinus children with cerebral palsy: A randomized clinical trial comparing two injection schedules. Journal of Neuroimmunology. 306. 31–39. 11 indexed citations
2.
Oshima, Minako, Philip R. Deitiker, Joseph Jankovic, K. Roger Aoki, & M. Zouhair Atassi. (2015). Submolecular recognition of the C-terminal domain of the heavy chain of botulinum neurotoxin type A by T cells from toxin-treated cervical dystonia patients. Immunobiology. 221(4). 568–576. 5 indexed citations
3.
Atassi, M. Zouhair, et al.. (2014). Synaptotagmin II and Gangliosides Bind Independently with Botulinum Neurotoxin B but Each Restrains the Other. The Protein Journal. 33(3). 278–288. 6 indexed citations
4.
Dupuy, Jérôme, Jeremy B. Nelson, Joanne Wang, et al.. (2013). Identification of Fibroblast Growth Factor Receptor 3 (FGFR3) as a Protein Receptor for Botulinum Neurotoxin Serotype A (BoNT/A). PLoS Pathogens. 9(5). e1003369–e1003369. 67 indexed citations
5.
Atassi, M. Zouhair, Joseph Jankovic, Lance E. Steward, K. Roger Aoki, & Behzod Z. Dolimbek. (2011). Molecular immune recognition of botulinum neurotoxin B. The light chain regions that bind human blocking antibodies from toxin-treated cervical dystonia patients. Antigenic structure of the entire BoNT/B molecule. Immunobiology. 217(1). 17–27. 16 indexed citations
6.
Takahara, Taro, Thomas C. Kwee, Hiroki Haradome, et al.. (2011). Peristalsis gap sign at cine magnetic resonance imaging for diagnosing strangulated small bowel obstruction: feasibility study. Japanese Journal of Radiology. 29(1). 11–18. 9 indexed citations
7.
Deitiker, Philip R., Minako Oshima, Joseph Jankovic, et al.. (2010). Association of HLA Class II alleles and haplotypes with cervical dystonia: HLA DR13-DQ6 (DQB1*0604) homozygotes are at greatly increased risk of cervical dystonia in Caucasian Americans. Autoimmunity. 44(3). 167–176. 11 indexed citations
8.
Chancellor, Michael B., Clare J. Fowler, Apostolos Apostolidis, et al.. (2008). Drug Insight: biological effects of botulinum toxin A in the lower urinary tract. Nature Clinical Practice Urology. 5(6). 319–328. 89 indexed citations
9.
Aoki, K. Roger. (2007). Future aspects of botulinum neurotoxins. Journal of Neural Transmission. 115(4). 567–573. 21 indexed citations
10.
Dolimbek, Behzod Z., Lance E. Steward, K. Roger Aoki, & M. Zouhair Atassi. (2007). Immune recognition of botulinum neurotoxin B: Antibody-binding regions on the heavy chain of the toxin. Molecular Immunology. 45(4). 910–924. 20 indexed citations
11.
Aoki, K. Roger, et al.. (2006). Mögliche antinozizeptive Mechanismen von Botulinumtoxin. Der Schmerz. 20(5). 381–387. 1 indexed citations
12.
Maruta, Takahiro, Behzod Z. Dolimbek, K. Roger Aoki, & M. Zouhair Atassi. (2006). Inhibition by human sera of botulinum neurotoxin-A binding to synaptosomes: A new assay for blocking and non-blocking antibodies. Journal of Neuroscience Methods. 151(2). 90–96. 11 indexed citations
13.
Lawrence, Gary W., et al.. (2006). Two Protein Trafficking Processes at Motor Nerve Endings Unveiled by Botulinum Neurotoxin E. Journal of Pharmacology and Experimental Therapeutics. 320(1). 410–418. 23 indexed citations
14.
Aoki, K. Roger, et al.. (2004). OPTIMIZATION OF HIP RESISTANCE SIMULATED ON DISARTICULATION PROSTHESIS BY PASSIVE SWING MODEL. Biomechanisms. 17. 217–226. 1 indexed citations
15.
Maruta, Takahiro, Behzod Z. Dolimbek, K. Roger Aoki, Lance E. Steward, & M. Zouhair Atassi. (2004). Mapping of the Synaptosome-Binding Regions on the Heavy Chain of Botulinum Neurotoxin A By Synthetic Overlapping Peptides Encompassing the Entire Chain. The Protein Journal. 23(8). 539–552. 23 indexed citations
16.
Aoki, K. Roger, et al.. (2003). Adaptive Control of Sewerage Systems using Distributed Reinforcement Learning. IEEJ Transactions on Industry Applications. 123(4). 462–469. 1 indexed citations
17.
Tang‐Liu, Diane, K. Roger Aoki, J. Oliver Dolly, et al.. (2003). Intramuscular injection of 125I-botulinum neurotoxin-complex versus 125I-botulinum-free neurotoxin: time course of tissue distribution. Toxicon. 42(5). 461–469. 76 indexed citations
18.
Aoki, K. Roger. (2002). Physiology and Pharmacology of Therapeutic Botulinum Neurotoxins. Current Problems in Dermatology. 30. 107–116. 16 indexed citations
19.
Orii, Kenji E., Hirofumi Kobayashi, Masato Ueno, et al.. (1997). [Mantle cell lymphoma with multiple extranodal involvement].. PubMed. 38(6). 520–5. 1 indexed citations
20.
Mori, Masahiro, et al.. (1997). Removal of Diluted NO Using Activated Carbon Fibers.. NIPPON KAGAKU KAISHI. 147–152. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026